Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers

被引:30
作者
Gallaway, M. Shayne [1 ]
Huang, Bin [2 ,3 ]
Chen, Quan [3 ]
Tucker, Thomas C. [3 ,4 ]
McDowell, Jaclyn K. [3 ]
Durbin, Eric [3 ,5 ]
Stewart, Sherri L. [1 ]
Tai, Eric [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Canc Prevent & Control, Natl Ctr Chron Dis Prevent & Hlth, 4770 Buford Highway,MS F76, Atlanta, GA 30341 USA
[2] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA
[3] Univ Kentucky, Coll Med, Kentucky Canc Registry, Lexington, KY USA
[4] Univ Kentucky, Coll Publ Hlth, Dept Epidemiol, Lexington, KY USA
[5] Univ Kentucky, Coll Med, Div Biomed Informat, Lexington, KY USA
关键词
Smoking; Smoking cessation; Tobacco-associated cancers; Health administrative claims; Linkage; Registry; CELL LUNG-CANCER; CIGARETTE-SMOKING; UNITED-STATES; HEALTH BEHAVIORS; SURVIVORS; MORTALITY; ADULTS; RISK; SURVEILLANCE; PREVALENCE;
D O I
10.1007/s10900-019-00622-z
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PurposeTo examine smoking and use of smoking cessation aids among tobacco-associated cancer (TAC) or non-tobacco-associated cancer (nTAC) survivors. Understanding when and if specific types of cessation resources are used can help with planning interventions to more effectively decrease smoking among all cancer survivors, but there is a lack of research on smoking cessation modalities used among cancer survivors.MethodsKentucky Cancer Registry data on incident lung, colorectal, pancreatic, breast, ovarian, and prostate cancer cases diagnosed 2007-2011, were linked with health administrative claims data (Medicaid, Medicare, private insurers) to examine the prevalence of smoking and use of smoking cessation aids 1year prior and 1year following the cancer diagnosis. TACs included colorectal, pancreatic, and lung cancers; nTAC included breast, ovarian, and prostate cancers.ResultsThere were 10,033 TAC and 13,670 nTAC survivors. Smoking before diagnosis was significantly higher among TAC survivors (p<0.0001). Among TAC survivors, smoking before diagnosis was significantly higher among persons who: were males (83%), aged 45-64 (83%), of unknown marital status (84%), had very low education (78%), had public insurance (89%), Medicaid (85%) or were uninsured (84%). Smoking cessation counseling and pharmacotherapy were more common among TAC than nTAC survivors (p<0.01 and p=0.05, respectively).DiscussionWhile smoking cessation counseling and pharmacotherapy were higher among TAC survivors, reducing smoking among all cancer survivors remains a priority, given cancer survivors are at increased risk for subsequent chronic diseases, including cancer. Tobacco cessation among all cancer survivors (not just those with TAC) can help improve prognosis, quality of life and reduce the risk of further disease. Health care providers can recommend for individual, group and telephone counseling and/or pharmacotherapy recommendations. These could also be included in survivorship care plans.
引用
收藏
页码:552 / 560
页数:9
相关论文
共 56 条
[41]   Smoking at diagnosis significantly decreases 5-year cancer-specific survival in a population-based cohort of 18 166 colon cancer patients [J].
Sharp, L. ;
McDevitt, J. ;
Brown, C. ;
Comber, H. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (06) :788-800
[42]   Cigarette Smoking Prior to First Cancer and Risk of Second Smoking-Associated Cancers Among Survivors of Bladder, Kidney, Head and Neck, and Stage I Lung Cancers [J].
Shiels, Meredith S. ;
Gibson, Todd ;
Sampson, Joshua ;
Albanes, Demetrius ;
Andreotti, Gabriella ;
Freeman, Laura Beane ;
de Gonzalez, Amy Berrington ;
Caporaso, Neil ;
Curtis, Rochelle E. ;
Elena, Joanne ;
Freedman, Neal D. ;
Robien, Kim ;
Black, Amanda ;
Morton, Lindsay M. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) :3989-U130
[43]   NICOTINE REPLACEMENT THERAPIES IN SMOKING CESSATION [J].
SILAGY, C .
BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (8-9) :407-408
[44]   Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: US Preventive Services Task Force Recommendation Statement [J].
Siu, Albert L. .
ANNALS OF INTERNAL MEDICINE, 2015, 163 (08) :622-+
[45]   Nicotine replacement therapy for smoking cessation: Cochrane systematic review [J].
Stead, L ;
Lancaster, T .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (05) :1001-1002
[46]  
Stead L, 2010, CANADIAN J DENT HYGI, V44, P84
[47]  
Stewart Sherri L., 2008, Morbidity and Mortality Weekly Report, V57, P1
[48]   Second primary cancers related to smoking and treatment of small-cell lung cancer [J].
Tucker, MA ;
Murray, N ;
Shaw, EG ;
Ettinger, DS ;
Mabry, M ;
Huber, MH ;
Feld, R ;
Shepherd, FA ;
Johnson, DH ;
Grant, SC ;
Aisner, J ;
Johnson, BE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (23) :1782-1788
[49]   A comparison of tobacco-related risk factors between adolescents with and without cancer [J].
Tyc, VL ;
Lensing, S ;
Klosky, J ;
Rai, SN ;
Robinson, L .
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2005, 30 (04) :359-370
[50]   Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis [J].
Underwood, J. Michael ;
Townsend, Julie S. ;
Tai, Eric ;
White, Arica ;
Davis, Shane P. ;
Fairley, Temeika L. .
JOURNAL OF CANCER SURVIVORSHIP, 2012, 6 (03) :333-344